Report cover image

Global Viral Vector Manufacturing Markets and Technologies Through 2030

Publisher BCC Research
Published Sep 30, 2025
Length 202 Pages
SKU # WA20476934

Description

Report Scope

This report analyzes viral vector manufacturing market trends using 2024 data, 2025 estimates, market projections and compound annual growth rates (CAGRs) for the forecast period of 2025–2030. The report discusses viral vector manufacturing’s current and future market potential and covers regulatory scenarios, drivers, restraints, and opportunities.

The report segments the market by type, application and disease. Types include adenoviral vectors (AdVs), adeno-associated viral vectors (AAVs), lentiviral vectors (LVs), retroviral vectors (RVs), and other viral vectors. Applications consist of multivalent and multipathogen. Diseases are segmented into human and veterinary. Human diseases are further segmented into HIV, tuberculosis, cancer, influenza, malaria, hepatitis, and others. Veterinary diseases are further segmented into avian influenza, Marek’s disease, infectious bronchitis, and PPR disease.

The market has been segmented into the regions of North America, Europe, Asia-Pacific, the Middle East and Africa (MEA), and South America. The markets of individual countries, including the U.S., Canada, Mexico, Germany, the U.K., France, Italy, Spain, Japan, China, South Korea, Australia, and India, are analyzed.

The goals of the report are to:
  • Analyze types of viral vectors.
  • Calculate the size of the global market size, with forecasts through 2030.
  • Identify market constraints and drivers.
  • Assess company’s market shares, competitiveness, and industry structure.
  • Identify potential long-term impacts on the viral vector manufacturing market.
Report Includes
  • Overview and analysis of the global viral vector manufacturing markets and technologies
  • Analyses of the global market trends, with historic sales revenue data from 2022 to 2024, estimates for 2025, and projected CAGRs through 2030
  • Estimates of the market’s size and revenue prospects, accompanied by a market share analysis based on type, application, disease segment and region
  • Facts and figures pertaining to market dynamics, technological advancements, regulations, prospects, and the impacts of macroeconomic variables
  • Insights derived from Porter’s Five Forces model and global value chain analysis
  • An assessment of the viral vaccine pipeline products, clinical trials, competitive scenario and R&D activities
  • An analysis of patents, emerging trends and new developments in the industry
  • Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
  • Analysis of the industry structure, including companies’ market shares and rankings, strategic alliances, and M&A activity
  • Profiles of the leading companies


Comapanies Mentioned

Abl Inc.
Catalent Inc.
Charles River Laboratories
Danaher Corp.
F. Hoffmann-la Roche Ltd.
Fujifilm Diosynth Biotechnologies
Lonza
Merck Kgaa
Novartis Ag
Oxford Biomedica Plc.
Probio
Revvity
Sanofi
Takara Bio Inc.
Thermo Fisher Scientific Inc.

Table of Contents

202 Pages
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Market Dynamics and Growth Factors
Emerging Technologies
Segmental Analysis
Regional Analysis
Conclusion
Chapter 2 Market Overview
Overview
Macroeconomic Factors
Impact of U.S. Tariffs on the Pharmaceutical Industry
Healthcare Expenditures
Impact of Global Economic Growth (GDP) on Pharma Sector
Direct Economic Impact
Indirect Economic Impact
Porter's Five Forces Analysis
Bargaining Power of Buyers
Bargaining Power of Suppliers
Potential for New Entrants to Market
Threat of Substitutes
Competitiveness in the Industry
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Increasing Incidence of Chronic Diseases
Approvals of Vector-Based Therapies
Demand for Viral Vector Production
Market Restraints
Process and Cost Barriers in Viral Vector Development
Viral Vector Roadblocks
High Cost Linked with Viral Vector Production
Market Opportunities
Emerging Viral-Based Therapies
Digitalization in Viral Vector Production
Chapter 4 Regulatory Landscape
Overview
United States
Europe
Japan
Chapter 5 Emerging Technologies and Pipeline Analysis
Overview
Automation
Next-Generation Production Systems
Genome Editing
Pipeline Analysis
Takeaways
Patent Analysis
Takeaways
Chapter 6 Market Segmentation Analysis
Segmentation Breakdown
Global Market for Viral Vector Manufacturing by Type
Lentiviral Vectors
Adenoviral Vectors
Adeno-Associated Viral Vectors
Retroviral Vectors (RVs)
Other Viral Vectors
Global Viral Vector Manufacturing Market, by Application
Multivalent Viral Vector Vaccines
Multipathogen Viral Vector Vaccines
Global Market for Viral Vector Manufacturing, by Disease
Veterinary Diseases
Human Diseases
Geographic Breakdown
Global Market for Viral Vector Manufacturing, by Region
North America
Europe
Asia-Pacific
Middle East and Africa
South America
Chapter 7 Competitive Intelligence
Market Share Analysis
Market Share Analysis
Recent Developments
Chapter 8 Sustainability in the Viral Vector Manufacturing Industry: An ESG Perspective
Introduction to ESG
Sustainability in the Viral Vector Manufacturing Industry
ESG Perspective
Environmental Impact
Waste Management
Social Impact
Governance Impact
ESG Risk Ratings
Conclusion
Chapter 9 Appendix
Methodology
Abbreviations
Sources
Company Profiles
ABL INC.
CATALENT INC.
CHARLES RIVER LABORATORIES
DANAHER CORP.
F. HOFFMANN-LA ROCHE LTD.
FUJIFILM DIOSYNTH BIOTECHNOLOGIES
LONZA
MERCK KGAA
NOVARTIS AG
OXFORD BIOMEDICA PLC.
PROBIO
REVVITY
SANOFI
TAKARA BIO INC.
THERMO FISHER SCIENTIFIC INC.
Emerging Players in the Viral Vector Manufacturing Market

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us